Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2 agonist vilanterol administered once daily for 52 weeks in patients >=12 years old with asthma: a randomised trial (Q36876695)
Jump to navigation
Jump to search
scientific article published on 25 February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2 agonist vilanterol administered once daily for 52 weeks in patients >=12 years old with asthma: a randomised trial |
scientific article published on 25 February 2013 |
Statements
1 reference
Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2 agonist vilanterol administered once daily for 52 weeks in patients >=12 years old with asthma: a randomised trial (English)
1 reference
William W Busse
1 reference
Eugene R Bleecker
1 reference
Eric D Bateman
1 reference
Loretta Jacques
1 reference
Leslie Andersen
1 reference
Wesley Hicks
1 reference
Jodie Crawford
1 reference
Ludovic Apoux
1 reference
25 February 2013
1 reference
1 reference
513-520
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference